Bird & Bird advised Biomemory on its €17 million fundraising round

International law firm Bird & Bird advised Biomemory, a French deeptech pioneer in DNA data storage, on its €17 million Series A funding round, with new investors Crédit Mutuel Innovation, Blast.club, Bpifrance, Sorbonne Venture and Adnexus, and its existing shareholders.

Founded in 2021, this innovative deeptech spin-off from CNRS/Sorbonne University’s first objective is to produce DNA printers that can transform binary information into AGTC information (the four types of DNA nucleotide).

Two years after a €5 million seed round, Biomemory plans to use this new funding to expand its team by recruiting promising talent in molecular biology and engineering to accelerate product development and commercialisation. 

The Bird & Bird team advising on the deal consisted of lead partner Félicien Bardsley and associate Céline Sol

News & Deals

More News & Deals

News

Bird & Bird appoints 17 to Partner, 5 to Senior Counsel, 34 to Counsel and 5 to Legal Director in annual global promotion round

Apr 30 2025

Read More

Deal

Bird & Bird advises IFX Payments on recommended offer for Argentex Group plc.

Apr 29 2025

Read More

News

Bird & Bird and OXYGY announce together with the European Commission the publication of the second best practices report 2025 for the European Blockchain Sandbox

Apr 29 2025

Read More

News

Bird & Bird recognised in Global Arbitration Review’s "GAR 100" list

Apr 25 2025

Read More

Deal

Bird & Bird advises the L'Oréal Group on its exclusive beauty partnership with JACQUEMUS, as well as on its minority stake acquisition

Apr 24 2025

Read More

News

Bird & Bird participates in JuriAI Ring to establish world’s first AI benchmarking index for legal sector

Apr 23 2025

Read More